{"id":"corticosteroids-for-systemic-use","safety":{"commonSideEffects":[{"rate":"10-30","effect":"Hyperglycemia"},{"rate":"10-20","effect":"Hypertension"},{"rate":"varies with duration","effect":"Osteoporosis"},{"rate":"20-40","effect":"Immunosuppression/increased infection risk"},{"rate":"10-15","effect":"Insomnia"},{"rate":"5-15","effect":"Mood changes (anxiety, depression)"},{"rate":"10-20","effect":"Gastrointestinal upset"},{"rate":"varies with dose and duration","effect":"Cushingoid features"}]},"_chembl":{"chemblId":"CHEMBL521875","moleculeType":"Small molecule","molecularWeight":"460.53"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Corticosteroids are synthetic derivatives of cortisol that act as potent anti-inflammatory and immunosuppressive agents. They bind to intracellular glucocorticoid receptors, translocate to the nucleus, and alter transcription of pro-inflammatory cytokines, adhesion molecules, and other mediators. This results in reduced recruitment and activation of immune cells, decreased vascular permeability, and suppression of both innate and adaptive immune responses.","oneSentence":"Corticosteroids suppress immune and inflammatory responses by binding to glucocorticoid receptors and modulating gene expression in immune cells.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:45:24.470Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Inflammatory and autoimmune disorders (systemic lupus erythematosus, rheumatoid arthritis, vasculitis)"},{"name":"Severe allergic reactions and anaphylaxis"},{"name":"Adrenal insufficiency"},{"name":"Chronic obstructive pulmonary disease exacerbations"},{"name":"Organ transplant rejection prophylaxis"}]},"trialDetails":[{"nctId":"NCT06859424","phase":"PHASE2","title":"A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation","status":"RECRUITING","sponsor":"Center for International Blood and Marrow Transplant Research","startDate":"2025-07-25","conditions":"AML (Acute Myelogenous Leukemia), Acute Lymphoid Leukemia (ALL), Acute Leukemia (Category)","enrollment":358},{"nctId":"NCT06246513","phase":"PHASE3","title":"A Trial to Learn More About an Experimental Gene Therapy Called Bidridistrogene Xeboparvovec (SRP-9003) as a Possible Treatment for Limb Girdle Muscular Dystrophy 2E/R4","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sarepta Therapeutics, Inc.","startDate":"2024-01-15","conditions":"Limb-girdle Muscular Dystrophy","enrollment":17},{"nctId":"NCT07431775","phase":"","title":"Saphnelo Use in Females of Child-bearing Potential","status":"NOT_YET_RECRUITING","sponsor":"AstraZeneca","startDate":"2026-10-01","conditions":"Systemic Lupus Erythematosus","enrollment":26000000},{"nctId":"NCT03656926","phase":"PHASE3","title":"Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Double Lung Transplant (BOSTON-2)","status":"COMPLETED","sponsor":"Zambon SpA","startDate":"2019-03-26","conditions":"Bronchiolitis Obliterans, Chronic Rejection of Lung Transplant, Lung Transplant Rejection","enrollment":169},{"nctId":"NCT07077486","phase":"PHASE4","title":"Effects of Telitacicept vs Cyclophosphamide on Lupus Related Interstitial Lung Disease","status":"RECRUITING","sponsor":"Tongji Hospital","startDate":"2025-08-25","conditions":"Lupus or SLE, Interstitial Lung Disease, Systemic Lupus Erythematosus","enrollment":100},{"nctId":"NCT07341776","phase":"PHASE4","title":"Steroid Use in Treatment of Allergic Reactions to Food","status":"RECRUITING","sponsor":"Johannes Trueck","startDate":"2026-01-26","conditions":"Anaphylactic Reaction, Anaphylaxis, Allergy in Children","enrollment":160},{"nctId":"NCT03621553","phase":"PHASE4","title":"Vitamin D Homeostasis in Sarcoidosis","status":"RECRUITING","sponsor":"University of Texas Southwestern Medical Center","startDate":"2010-07-01","conditions":"Sarcoidosis, Vitamin D Insufficiency","enrollment":90},{"nctId":"NCT03657342","phase":"PHASE3","title":"Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Single Lung Transplant (BOSTON-1)","status":"COMPLETED","sponsor":"Zambon SpA","startDate":"2019-03-26","conditions":"Bronchiolitis Obliterans, Chronic Rejection of Lung Transplant, Lung Transplant Rejection","enrollment":62},{"nctId":"NCT05306873","phase":"PHASE2","title":"Examining Distinct Immunophenotypes to Validate and Enhance Rational Treatment in Systemic Lupus","status":"TERMINATED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2022-11-30","conditions":"Systemic Lupus Erythematosus","enrollment":12},{"nctId":"NCT07021495","phase":"","title":"SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)","status":"RECRUITING","sponsor":"Leiden University Medical Center","startDate":"2025-07-29","conditions":"Chronic Spontaneous Urticaria (CSU), Hidradenitis Suppurativa (HS), Psoriasis (PsO)","enrollment":840},{"nctId":"NCT01718197","phase":"","title":"Severe Asthma Research Program (SARP)- San Francisco Clinical Site","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2012-11","conditions":"Asthma","enrollment":151},{"nctId":"NCT02103348","phase":"","title":"Characterizing Asthma Sputum Elasticity in the UCSF Severe Asthma Research Program","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2015-09","conditions":"Asthma","enrollment":25},{"nctId":"NCT04921189","phase":"PHASE2","title":"Steroid, Thiamine and Ascorbic Acid for Comatose Out-of-hospital Cardiac Arrest Survivors","status":"COMPLETED","sponsor":"Asan Medical Center","startDate":"2021-12-31","conditions":"Out-Of-Hospital Cardiac Arrest, Postcardiac Arrest Syndrome","enrollment":160},{"nctId":"NCT06967363","phase":"","title":"Multimodal Imaging and Biospecimen Collection for Low Back Pain (LBPB)","status":"NOT_YET_RECRUITING","sponsor":"Peking University Third Hospital","startDate":"2025-05-15","conditions":"Chronic Low Back Pain (CLBP), Acute Low Back Pain, Low Back Pain","enrollment":360},{"nctId":"NCT02386735","phase":"NA","title":"Reduction of Corticosteroid Use in Outpatient Treatment of Exacerbated COPD","status":"TERMINATED","sponsor":"Prof. Dr. Jörg Leuppi","startDate":"2015-03","conditions":"Pulmonary Disease, Chronic Obstructive, Adverse Effect of Glucocorticoids and Synthetic Analogues, Disease Exacerbation","enrollment":133},{"nctId":"NCT03526861","phase":"PHASE3","title":"Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema TRAlokinumab Trial no. 6).","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2018-06-19","conditions":"Atopic Dermatitis","enrollment":301},{"nctId":"NCT06768294","phase":"PHASE2","title":"Baricitinib in CPPD - the BAPTIST Study","status":"NOT_YET_RECRUITING","sponsor":"I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio","startDate":"2025-01","conditions":"Calcium Pyrophosphate Deposition Disease, Chondrocalcinosis","enrollment":32},{"nctId":"NCT05638932","phase":"","title":"Methodologies for Observational Studies Comparing Inpatient COVID-19 Treatments","status":"COMPLETED","sponsor":"Aetion, Inc.","startDate":"2020-06-16","conditions":"COVID-19","enrollment":1442},{"nctId":"NCT02108860","phase":"PHASE3","title":"Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's)","status":"COMPLETED","sponsor":"University of South Florida","startDate":"2015-04-25","conditions":"Granulomatosis With Polyangiitis (Wegener's), Granulomatosis With Polyangiitis, Wegener's Granulomatosis","enrollment":65},{"nctId":"NCT01933724","phase":"PHASE3","title":"The Assessment of Prednisone In Remission Trial (TAPIR) - Patient Centric Approach","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of South Florida","startDate":"2014-02-17","conditions":"Granulomatosis With Polyangiitis, Wegener Granulomatosis, Vasculitis","enrollment":12},{"nctId":"NCT02735707","phase":"PHASE3","title":"Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia","status":"RECRUITING","sponsor":"UMC Utrecht","startDate":"2016-04-11","conditions":"Community-acquired Pneumonia, Influenza, COVID-19","enrollment":20000},{"nctId":"NCT05916781","phase":"PHASE4","title":"Effectiveness of Mycophenolate Mofetil Combined With Tacrolimus for Steroid Tapering in Systemic Lupus Erythematosus","status":"RECRUITING","sponsor":"Chinese SLE Treatment And Research Group","startDate":"2023-07-01","conditions":"Systemic Lupus Erythematosus, Lupus Nephritis","enrollment":220},{"nctId":"NCT02741271","phase":"PHASE3","title":"Study of Efficacy and Long-Term Safety of Mometasone Furoate in Combination With Formoterol Fumarate Versus Mometasone Furoate in Children (5 to 11 Years of Age) With Persistent Asthma (MK-0887A-087)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2016-05-11","conditions":"Asthma","enrollment":181},{"nctId":"NCT01903317","phase":"","title":"Evaluation of Vitamin D Levels in Psoriasis Patients","status":"WITHDRAWN","sponsor":"University of California, Irvine","startDate":"2013-06","conditions":"Psoriasis","enrollment":""},{"nctId":"NCT06297408","phase":"PHASE1","title":"Relma-cel for Moderate to Severe Active Systemic Lupus Erythematosus","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Ming Ju Biotechnology Co., Ltd.","startDate":"2024-03","conditions":"Systemic Lupus Erythematosus","enrollment":24},{"nctId":"NCT03301883","phase":"PHASE4","title":"A Study of Tocilizumab in Chinese Participants With Systemic Juvenile Idiopathic Arthritis (sJIA)","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2018-04-26","conditions":"Juvenile Idiopathic Arthritis","enrollment":62},{"nctId":"NCT06178146","phase":"PHASE4","title":"Thymosin Alpha-1 for irAE Secondary to ICIs","status":"UNKNOWN","sponsor":"Jun Wang","startDate":"2023-09-01","conditions":"IrAE","enrollment":40},{"nctId":"NCT04726553","phase":"EARLY_PHASE1","title":"Nature of Anifrolumab Impact on Vaccine-Emergent Immunity in SLE","status":"UNKNOWN","sponsor":"Oklahoma Medical Research Foundation","startDate":"2021-01-20","conditions":"Systemic Lupus Erythematosus (SLE)","enrollment":20},{"nctId":"NCT01086540","phase":"PHASE2","title":"Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2011-06-24","conditions":"Systemic Sclerosis-Associated PAH","enrollment":57},{"nctId":"NCT01874860","phase":"PHASE2","title":"Skin Rash Study Before Chemotherapy in Colorectal & Head and Neck Cancer Patients","status":"COMPLETED","sponsor":"University of Louisville","startDate":"2013-08","conditions":"Colorectal Cancer, Head and Neck Cancer","enrollment":24},{"nctId":"NCT05605145","phase":"","title":"PCP in Immunocompromised Population in Southern China","status":"UNKNOWN","sponsor":"First Affiliated Hospital of Guangxi Medical University","startDate":"2021-05-12","conditions":"Immunocompromised Patients, Pneumocystis Pneumonia, Diagnosis","enrollment":300},{"nctId":"NCT05140616","phase":"PHASE1, PHASE2","title":"Study of Chidamide for Steroid-resistant/Steroid-dependent Severe cGVHD","status":"UNKNOWN","sponsor":"The First Affiliated Hospital of Soochow University","startDate":"2021-05-31","conditions":"Safety and Efficacy","enrollment":20},{"nctId":"NCT03629249","phase":"PHASE3","title":"Systemic Corticosteroids Avoidance Study in Severe Asthma Patients","status":"TERMINATED","sponsor":"Novartis Pharmaceuticals","startDate":"2018-12-13","conditions":"Asthma","enrollment":604},{"nctId":"NCT04878770","phase":"NA","title":"NMF-CsA-Dupi Trial","status":"UNKNOWN","sponsor":"Erasmus Medical Center","startDate":"2021-08-16","conditions":"Dermatitis, Atopic","enrollment":318},{"nctId":"NCT03345407","phase":"PHASE2","title":"Dose Finding Study of Nemiralisib (GSK2269557) in Subjects With an Acute Moderate or Severe Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)","status":"TERMINATED","sponsor":"GlaxoSmithKline","startDate":"2017-11-28","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":943},{"nctId":"NCT02266433","phase":"PHASE3","title":"Dexamethasone Versus Ketorolac Injection for the Treatment of Local Inflammatory Hand and Upper Extremity Disorders","status":"TERMINATED","sponsor":"NYU Langone Health","startDate":"2012-08","conditions":"DeQuervains Tenosynovitis, Lateral Epicondylitis, Tennis Elbow","enrollment":245},{"nctId":"NCT02717871","phase":"PHASE3","title":"Swiss PACK-CXL Multicenter Trial for the Treatment of Infectious Keratitis","status":"COMPLETED","sponsor":"University Hospital, Geneva","startDate":"2016-03","conditions":"Keratitis; Infectious Disease (Manifestation)","enrollment":35},{"nctId":"NCT04012905","phase":"PHASE3","title":"Giant Cell Arteritis: Comparison Between Two Standardized Corticosteroids Tapering","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Caen","startDate":"2020-11-05","conditions":"Giant Cell Arteritis","enrollment":150},{"nctId":"NCT04445506","phase":"","title":"Short Term Corticosteroids in SARS-CoV2 Patients","status":"COMPLETED","sponsor":"The Miriam Hospital","startDate":"2020-04-01","conditions":"Corticosteroids, Covid19, SARS-CoV 2","enrollment":50},{"nctId":"NCT02666703","phase":"PHASE3","title":"Extracorporeal Cytokine Adsorption in Cardiac Surgery","status":"COMPLETED","sponsor":"University Medical Centre Ljubljana","startDate":"2016-02-01","conditions":"Cardiopulmonary Bypass","enrollment":60},{"nctId":"NCT03290222","phase":"","title":"TRACK: Validation of the Portuguese Version","status":"COMPLETED","sponsor":"Federal University of São Paulo","startDate":"2017-08-22","conditions":"Asthma, Respiratory Disease","enrollment":299},{"nctId":"NCT01196091","phase":"PHASE3","title":"A Study of LY2127399 in Participants With Systemic Lupus Erythematosus","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2010-12","conditions":"Systemic Lupus Erythematosus, Connective Tissue Disease, Autoimmune Disease","enrollment":1164},{"nctId":"NCT03498742","phase":"","title":"Asthmatic Subjects Could Live Without Short Acting beta2 Agonists","status":"COMPLETED","sponsor":"Universidad Nacional de Rosario","startDate":"2017-03-10","conditions":"Asthma Chronic","enrollment":86},{"nctId":"NCT01676415","phase":"PHASE4","title":"Corticosteroid Therapy for Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)","status":"TERMINATED","sponsor":"Northwestern University","startDate":"2012-08","conditions":"Chronic Rhinosinusitis Without Nasal Polyps","enrollment":9},{"nctId":"NCT00514982","phase":"PHASE2","title":"Medical Treatment of Colitis in Patients With Hermansky-Pudlak Syndrome","status":"WITHDRAWN","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2007-08-07","conditions":"Hermanski-Pudlak Syndrome, Colitis, Cytokines","enrollment":""},{"nctId":"NCT00642460","phase":"PHASE3","title":"A Study of RoActemra/Actemra (Tocilizumab) in Patients With Active Systemic Juvenile Idiopathic Arthritis (JIA)","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2008-05","conditions":"Juvenile Idiopathic Arthritis","enrollment":112},{"nctId":"NCT01991236","phase":"NA","title":"Video-Based Education for Dermatology Patients on Systemic Corticosteroids","status":"COMPLETED","sponsor":"Emory University","startDate":"2013-04","conditions":"Chronic Inflammatory Skin Diseases","enrollment":75},{"nctId":"NCT00004500","phase":"PHASE3","title":"Phase III Randomized Study of Lucinactant in Full Term Newborn Infants With Meconium Aspiration Syndrome","status":"TERMINATED","sponsor":"Windtree Therapeutics","startDate":"2000-03","conditions":"Meconium Aspiration","enrollment":69},{"nctId":"NCT01456377","phase":"NA","title":"The Effectiveness of Oral Corticosteroids in the Treatment of Lumbar Stenosis","status":"UNKNOWN","sponsor":"Federal University of São Paulo","startDate":"2011-07","conditions":"Spinal Stenosis of Lumbar Region","enrollment":60},{"nctId":"NCT01228695","phase":"","title":"Prospective Study of the Impact of Systemic Corticosteroid Use on Measures of Sleep Disordered Breathing","status":"COMPLETED","sponsor":"Rambam Health Care Campus","startDate":"2007-01","conditions":"Sleep Apnea","enrollment":20}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Corticosteroids for Systemic Use","genericName":"Corticosteroids for Systemic Use","companyName":"University Hospital, Caen","companyId":"university-hospital-caen","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Corticosteroids suppress immune and inflammatory responses by binding to glucocorticoid receptors and modulating gene expression in immune cells. Used for Inflammatory and autoimmune disorders (systemic lupus erythematosus, rheumatoid arthritis, vasculitis), Severe allergic reactions and anaphylaxis, Adrenal insufficiency.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}